HomeFileCoronary disease

Coronary disease

ESC 2018 | CULPRIT-SHOCK: 1-Year Results Continue to Support Treatment of the Culprit Artery Only

Increases in the rates of revascularization and heart failure do not justify the early mortality advantage shown...

ESC 2018 | MATRIX: 1-Year Superiority of Transradial Access

Transradial access should be the access of choice in patients with acute coronary syndrome, while bivalirudin has...

ESC 2018 | FUTURE: A Thorn in FFR and More Questions than Answers

As observed at the preliminary analysis that motivated the FUTURE trial early termination, the use of fractional...

SOLACI-SOCIME 2018 | New Indications

Read articles on the main presentations of the first day of SOLACI-SOCIME 2018 Congress. See the presentation by Dr....

What Happens with Small Dissections and Imperfections Only Shown by OCT?

When we carry out an angioplasty guided by angiography alone, as we historically have, we are almost...

The Dangerous Combination of Complex Angioplasty and High Bleeding Risk Seems to Have a Solution

The LEADERS FREE trial demonstrated that a polymer-free Biolimus A9-coated stent (BioFreedom™DCS; Biosensors Europe, Morges, Switzerland) is...

Women in Cardiology: Still Underrepresented in a Field Full of Men

JAMA Cardiology dedicated a special with 4 articles on different issues women continue to face when considering...

Left Main PCI: Despite Auspicious Long-Term Outcomes, Optimal Strategy Still under Discussion

Left main coronary artery bifurcation interventions have shown very good results at long term, especially with new...